ConductScience.org, home

Paper36856424

Colistin Enhances Rifampicin's Antimicrobial Action in Colistin-Resistant Pseudomonas aeruginosa Biofilms.

Armengol E and 7 others. Antimicrob Agents Chemother, 2023. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Colistin Enhances Rifampicin's Antimicrobial Action in Colistin-Resistant Pseudomonas aeruginosa Biofilms. Papers, record 36856424. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36856424

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Colistin Enhances Rifampicin's Antimicrobial Action in Colistin-Resistant Pseudomonas aeruginosa Biofilms.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
2.4
iCite
Revised in PubMed
2023-09-02
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Armengol EEva
2Kragh KNKasper Nørskovhttps://orcid.org/0000-0002-7662-9118
3Tolker-Nielsen TTimhttps://orcid.org/0000-0002-9751-474X
4Sierra JMJosep Mhttps://orcid.org/0000-0002-0997-5619
5Higazy DDoaa
6Ciofu OOana
7Viñas MMiguel
8Høiby NNiels

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ColistinMajor topic
Pseudomonas InfectionsMajor topic
Humans
Pseudomonas aeruginosa
Rifampin
Anti-Bacterial Agents
Biofilms
Microbial Sensitivity Tests

Source PubMed

Download CSV of topics

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133214718Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis.Nat Rev Microbiol2021https://conductscience.org/library/papers/33214718PubMed
232784516Polymyxins and Bacterial Membranes: A Review of Antibacterial Activity and Mechanisms of Resistance.Membranes (Basel)2020https://conductscience.org/library/papers/32784516PubMed
331977044Effect of colistin-based antibiotic combinations on the eradication of persister cells in Pseudomonas aeruginosa.J Antimicrob Chemother2020https://conductscience.org/library/papers/31977044PubMed
418358794Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients.J Cyst Fibros2008https://conductscience.org/library/papers/18358794PubMed
5341778262-Heptylcyclopropane-1-Carboxylic Acid Disperses and Inhibits Bacterial Biofilms.Front Microbiol2021https://conductscience.org/library/papers/34177826PubMed
617682994Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.Clin Infect Dis2007https://conductscience.org/library/papers/17682994PubMed
731372011Efficacy of combinations of colistin with other antimicrobials involves membrane fluidity and efflux machinery.Infect Drug Resist2019https://conductscience.org/library/papers/31372011PubMed
828368216An overview of antimicrobial peptides and the latest advances in their development.Expert Opin Biol Ther2017https://conductscience.org/library/papers/28368216PubMed
919231985Multidrug resistance in bacteria.Annu Rev Biochem2009https://conductscience.org/library/papers/19231985PubMed
1028874373Hyperbaric Oxygen Sensitizes Anoxic Pseudomonas aeruginosa Biofilm to Ciprofloxacin.Antimicrob Agents Chemother2017https://conductscience.org/library/papers/28874373PubMed
1130803159Optimization of colistin dosing regimen for cystic fibrosis patients with chronic Pseudomonas aeruginosa biofilm lung infections.Pediatr Pulmonol2019https://conductscience.org/library/papers/30803159PubMed
1233821795Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane.Elife2021https://conductscience.org/library/papers/33821795PubMed
1311348676A panel of Tn7-based vectors for insertion of the gfp marker gene or for delivery of cloned DNA into Gram-negative bacteria at a neutral chromosomal site.J Microbiol Methods2001https://conductscience.org/library/papers/11348676PubMed
1418312276Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes.Mol Microbiol2008https://conductscience.org/library/papers/18312276PubMed
1530376071
Triple combination of meropenem, colistin and tigecycline was bactericidal in a dynamic model despite mere additive interactions in chequerboard assays against carbapenemase-producing Klebsiella pneumoniae isolates.
J Antimicrob Chemother2019https://conductscience.org/library/papers/30376071PubMed
1619243444Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa.FEMS Microbiol Rev2009https://conductscience.org/library/papers/19243444PubMed
1730683887Drug combinations: a strategy to extend the life of antibiotics in the 21st century.Nat Rev Microbiol2019https://conductscience.org/library/papers/30683887PubMed
1830711384Hyperbaric oxygen treatment increases killing of aggregating Pseudomonas aeruginosa isolates from cystic fibrosis patients.J Cyst Fibros2019https://conductscience.org/library/papers/30711384PubMed
1923459479Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23459479PubMed
2033672663The History of Colistin Resistance Mechanisms in Bacteria: Progress and Challenges.Microorganisms2021https://conductscience.org/library/papers/33672663PubMed

See all 37 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42967945Characterization and treatment of polymicrobial biofilms in prosthetic joint infections.Appl Microbiol Biotechnol2026https://conductscience.org/library/papers/42967945PubMed
42774664The activity of a new bicyclic peptide, PLP-3, against colistin-resistant Pseudomonas aeruginosa biofilms.Biofilm2026https://conductscience.org/library/papers/42774664PubMed
41900883Chemical Characterization and Evaluation of Antimicrobial, Antioxidant, and Synergistic Activities of Teucrium polium L.: An Integrated Experimental and In Silico Approach.Pharmaceutics2026https://conductscience.org/library/papers/41900883PubMed
41312994Synergistic activity of rifampicin and polymyxin B against intracellular Gram-negative ESKAPE pathogens involves bacterial membrane alterations and enhanced oxidative damages.Antimicrob Agents Chemother2026https://conductscience.org/library/papers/41312994PubMed
40558147Outbreak of NDM-5-Producing Proteus mirabilis During the COVID-19 Pandemic in an Argentine Hospital.Antibiotics (Basel)2025https://conductscience.org/library/papers/40558147PubMed
39597505Pseudomonas aeruginosa in the Frontline of the Greatest Challenge of Biofilm Infection-Its Tolerance to Antibiotics.Microorganisms2024https://conductscience.org/library/papers/39597505PubMed
39445123Synergistic combinations of novel polymyxins and rifampicin with improved eradication of colistin-resistant Pseudomonas aeruginosa biofilms.Biofilm2024https://conductscience.org/library/papers/39445123PubMed
39402397Biofilm matrix: a multifaceted layer of biomolecules and a defensive barrier against antimicrobials.Arch Microbiol2024https://conductscience.org/library/papers/39402397PubMed
39061324Impact of Growth Conditions on High-Throughput Identification of Repurposing Drugs for Pseudomonas aeruginosa Cystic Fibrosis Lung Infections.Antibiotics (Basel)2024https://conductscience.org/library/papers/39061324PubMed
38668338
A Study of the Synergistic Effects of Essential Oils from Origanum compactum and Origanum elongatum with Commercial Antibiotics against Highly Prioritized Multidrug-Resistant Bacteria for the World Health Organization.
Metabolites2024https://conductscience.org/library/papers/38668338PubMed
38258128Antibiotics against Pseudomonas aeruginosa on Human Skin Cell Lines: Determination of the Highest Non-Cytotoxic Concentrations with Antibiofilm Capacity for Wound Healing Strategies.Pharmaceutics2024https://conductscience.org/library/papers/38258128PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36856424

GET https://conductscience.org/api/papers/v1/36856424/references?page=2